The global parenteral nutrition market size is expected to reach USD 8.26 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing rate of natality and surging geriatric population is fueling the market growth.
As
of 2014, the natality rate reported by the National Center for Health
Statistics (NCHS) is 12.5 births per 1,000 populations in U.S. Furthermore, the
percentage of lower weight infants was 8.0%, thereby boosting the demand for
parenteral nutrition products in the country.
The
realized natality is rising over the last decade and is anticipated to sustain
growth over the forecast period. However, in 2011, a dip was witnessed in U.S.
owing to alteration in fertility rate of the local female population. However,
in the same year, hike in the number of births for foreign based immigrant
citizens was also observed leading to an overall rise in birth rate.
Moreover,
a large number of premature babies suffer from low weight as well as
undeveloped immunity thus putting them at risk. Parenteral nutrition reduces
the risk of infection and underdevelopment, thereby promoting its application.
As
per the National Center for Healthcare Statistics, the premature birth rate of
the U.S. is about 9.6% as of 2016, and the national authorities are working to
reduce it to 8.1%.
In
very low birth weight (VLBW) newborns, demand for parenteral nutrition is
higher owing to low prospect of enteral nutrition. Hence, use of parenteral
nutrition in premature infants results in improved intrauterine nutrient
deposition, faster neurological development, and minimized risk of
complications thus improving their chances for survival.
Full Research Report On Parenteral Nutrition Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market
Further key
findings from the study suggest:
- Single dose amino acid
solution segment dominated the market in 2018 owing to increasing use of
amino acid solutions that possess fewer side effects thus enhancing
patient benefits
- North America led the market
in terms of revenue and accounted for 41.73% of the overall share in 2018.
Presence of high research expenditure by private entities and government
agencies in the healthcare sector and collaborations among medical device
industry, regulatory authorities, and universities are responsible for the
market growth
- Some of the companies
present in the parenteral nutrition market are B. Braun Melsungen AG;
Baxter International, Inc.; Fresenius Kabi AG; Hospira, Inc.; Actavis,
Inc.; Grifols International S.A.; Otsuka Pharmaceutical Factory, Inc.; and
Sichuan Kelun Pharmaceutical Co. Ltd.
Request
a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market/request/rs1
Grand View Research has segmented
the global parenteral nutrition market based on nutrient type and region:
Parenteral
Nutrition Nutrient Type Outlook (Revenue, USD Million, 2015 - 2026)
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid
Solution
- Trace Elements
- Vitamins & Minerals
Parenteral
Nutrition Regional Outlook (Revenue, USD Million, 2015 – 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Spain
- Italy
- France
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment